These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

517 related items for PubMed ID: 28655421

  • 1. Synthesis and evaluation of hydroxychalcones as multifunctional non-purine xanthine oxidase inhibitors for the treatment of hyperuricemia.
    Xie Z, Luo X, Zou Z, Zhang X, Huang F, Li R, Liao S, Liu Y.
    Bioorg Med Chem Lett; 2017 Aug 01; 27(15):3602-3606. PubMed ID: 28655421
    [Abstract] [Full Text] [Related]

  • 2. 3,5,2',4'-Tetrahydroxychalcone, a new non-purine xanthine oxidase inhibitor.
    Niu Y, Zhu H, Liu J, Fan H, Sun L, Lu W, Liu X, Li L.
    Chem Biol Interact; 2011 Feb 01; 189(3):161-6. PubMed ID: 21167141
    [Abstract] [Full Text] [Related]

  • 3. Identification of the biologically active constituents of Camellia japonica leaf and anti-hyperuricemic effect in vitro and in vivo.
    Yoon IS, Park DH, Kim JE, Yoo JC, Bae MS, Oh DS, Shim JH, Choi CY, An KW, Kim EI, Kim GY, Cho SS.
    Int J Mol Med; 2017 Jun 01; 39(6):1613-1620. PubMed ID: 28487949
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. 3,4-Dihydroxy-5-nitrobenzaldehyde (DHNB) is a potent inhibitor of xanthine oxidase: a potential therapeutic agent for treatment of hyperuricemia and gout.
    Lü JM, Yao Q, Chen C.
    Biochem Pharmacol; 2013 Nov 01; 86(9):1328-37. PubMed ID: 23994369
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Design, synthesis and biological evaluation of novel xanthine oxidase inhibitors bearing a 2-arylbenzo[b]furan scaffold.
    Tang HJ, Li W, Zhou M, Peng LY, Wang JX, Li JH, Chen J.
    Eur J Med Chem; 2018 May 10; 151():849-860. PubMed ID: 29684895
    [Abstract] [Full Text] [Related]

  • 10. Discovery of novel curcumin derivatives targeting xanthine oxidase and urate transporter 1 as anti-hyperuricemic agents.
    Ao GZ, Zhou MZ, Li YY, Li SN, Wang HN, Wan QW, Li HQ, Hu QH.
    Bioorg Med Chem; 2017 Jan 01; 25(1):166-174. PubMed ID: 28340987
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Design, synthesis, and biological evaluation of N-(3-cyano-1H-indol-5/6-yl)-6-oxo-1,6-dihydropyrimidine-4-carboxamides and 5-(6-oxo-1,6-dihydropyrimidin-2-yl)-1H-indole-3-carbonitriles as novel xanthine oxidase inhibitors.
    Zhang B, Duan Y, Yang Y, Mao Q, Lin F, Gao J, Dai X, Zhang P, Li Q, Li J, Dai R, Wang S.
    Eur J Med Chem; 2022 Jan 05; 227():113928. PubMed ID: 34688012
    [Abstract] [Full Text] [Related]

  • 13. Discovery of 4-(phenoxymethyl)-1H-1,2,3-triazole derivatives as novel xanthine oxidase inhibitors.
    Zhang TJ, Zhang Y, Zhang ZH, Wang ZR, Zhang X, Hu SS, Lu PF, Guo S, Meng FH.
    Bioorg Med Chem Lett; 2022 Mar 15; 60():128582. PubMed ID: 35077850
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Synthesis of pyrimidones and evaluation of their xanthine oxidase inhibitory and antioxidant activities.
    Gurupadaswamy HD, Girish V, Zameer F, Hegdekatte R, Chauhan JB, Khanum SA.
    Arch Pharm (Weinheim); 2013 Nov 15; 346(11):805-11. PubMed ID: 24114987
    [Abstract] [Full Text] [Related]

  • 18. Novel 3-[4-alkoxy-3-(1H-tetrazol-1-yl) phenyl]-1,2,4-oxadiazol-5(4H)-ones as promising xanthine oxidase inhibitors: Design, synthesis and biological evaluation.
    Gao J, Zhang Z, Zhang B, Mao Q, Dai X, Zou Q, Lei Y, Feng Y, Wang S.
    Bioorg Chem; 2020 Jan 15; 95():103564. PubMed ID: 31927335
    [Abstract] [Full Text] [Related]

  • 19. Computational Analysis and Synthesis of Syringic Acid Derivatives as Xanthine Oxidase Inhibitors.
    Malik N, Khatkar A, Dhiman P.
    Med Chem; 2020 Jan 15; 16(5):643-653. PubMed ID: 31584375
    [Abstract] [Full Text] [Related]

  • 20. Effects of lobetyolin on xanthine oxidase activity in vitro and in vivo: weak and mixed inhibition.
    Yoon IS, Cho SS.
    Nat Prod Res; 2021 May 15; 35(10):1667-1670. PubMed ID: 31140315
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.